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Background/Purpose: There have been many conﬂicting reports on the effects of type 2 diabetes mellitus
(DM) and the level of vitamin B12 on bone mineral density (BMD) in elderly patients. Moreover, con-
ﬂicting data exists regarding the prevalence of vitamin B12 deﬁciency among elderly diabetics. The aim
of this study was to investigate the link between vitamin B12 levels, type 2 DM, and BMD in elderly
patients.
Methods: A caseecontrol study was conducted on 61 participants, 60 years of age, divided into 31 cases
of patients with diabetes and 30 age-matched healthy controls. Patients receiving vitamin B12 supple-
ments were excluded. The relationship between BMD and serum levels of vitamin B12 was examined.
Results: Borderline/deﬁcient serum B12 status was more common in the control group; it was found in
53.33% of the controls and 25.80% of diabetic patients. The mean serum vitamin B12 concentration was
820.65 ± 544.77 pg/mL in patients with diabetes and 677.80 ± 619.89 pg/mL in healthy control partic-
ipants (p ¼ 0.34). Serum vitamin B12 concentration showed no signiﬁcant difference between osteo-
porotic patients, osteopenic patients, and normal patients among the diabetic group.
Conclusion: The prevalence of vitamin B12 deﬁciency was higher in the control group than the diabetic
group who did not receive oral B12 supplementation. Low serum vitamin B12 is commonly overlooked in
the elderly, with or without diabetes. The presence of diabetes mellitus did not affect BMD in the elderly.
Furthermore, there is no signiﬁcant relationship between serum vitamin B12 levels and BMD among
diabetics.
Copyright © 2015, Asia Paciﬁc League of Clinical Gerontology & Geriatrics. Published by Elsevier Taiwan
LLC.  Open access under CC BY-NC-ND license.1. Introduction
Diabetes mellitus (DM) is a prevalent disease with multiple
alarming complications that represent major threats to one's gen-
eral health.1 These complications are often associated with poor
prognosis, increased morbidity, and impaired quality of life.
Furthermore, the life span of patients with DM is dependent upon
the presence/absence of these complications.2
One of the most overlooked complications of diabetes is oste-
oporosis, which has not been listed as a traditional diabetic
complication. However, patients with either type 1 DM or type 2sis Street, Abbassya Square,
heedy).
linical Gerontology & Geriatrics. PDM are considered to be at an increased risk of developing osteo-
porotic fractures.3
Although there is a strong correlation between the reduction of
bone mineral density (BMD) and type 1 DM,4 there is a lack of data
on the occurrence of osteoporosis in type 2 DM. The BMD of pa-
tients with type 2 diabetes was found to be lower, equal, or even
higher when compared with their healthy counterparts.5e7
There are many proposed pathological mechanisms by which
type 2 DM can affect bone tissue; these include obesity, hyper-
insulinemia, the deposition of advanced glycosylation end-
products in collagen ﬁbers, reduced circulating levels of insulin
growth factor-1, hypercalciuria, renal affection, microangiopathy,
and chronic inﬂammatory state.8
Moreover, a variety of dietary factors have been linked to the
occurrence of osteoporosis, e.g., inadequate levels of protein, cal-
cium, and vitamin D. Recently there has been an increased interestublished by Elsevier Taiwan LLC. Open access under CC BY-NC-ND license.
M.S. Amer et al. / Journal of Clinical Gerontology & Geriatrics 6 (2015) 120e124 121in studying the effects of other nutrients, including vitamin B12, on
bone health.9
The mechanism by which vitamin B12 deﬁciency can alter bone
health is by inducing hyperhomocysteinemia, which interferes
with collagen cross-linking, causing an altered bone matrix
resulting in more fragile bones.10
Previous studies of the association between vitamin B12 level
and BMD showed diverse results. Some researchers linked osteo-
porosis to low vitamin B12 levels,11 whereas others did not observe
an association between vitamin B12 status and BMD.12,13
The relationship between vitamin B12 level and BMD in elderly
patients with and without type 2 DM remains inconclusive.
Therefore, the aim of this study was to study the link between
vitamin B12, type 2 DM, and BMD in elderly patients.
2. Method
2.1. Study population
Sixty-one elderly patients, aged  60 years, attended the
outpatient clinic at Ain Shams University Hospital, Cairo, Egypt.
Thirty-one patients with type 2 DM and 30 healthy participants
were recruited in the study.
Diabetes mellitus, as deﬁned according to the American Dia-
betes Association criteria (fasting plasma glucose  126 mg/dL;
minimum of 8 hours fasting), a random or postload serum glucose
level  200 mg/dL after an oral glucose tolerance test, or the use of
hypoglycemic medication.14 All participants underwent compre-
hensive geriatric assessment that included detailed personal and
medical histories, physical examination, and cognitive, functional,
and mood assessment tests.
Patients with a history of pernicious anemia, chronic renal
insufﬁciency as deﬁned by a creatinine level  1.5 mg/dL, prior
bariatric surgery, gastrectomy, vitamin B12 supplementation of any
form, prior ileum resection, and Crohn's disease were excluded
from the study. Data regarding the intake of metformin, other
antidiabetic drugs, and insulin were collected.
2.2. BMD measurement
Bone densitometry was performed on all patients by dual en-
ergy X-ray absorptiometry, using a Lunar DpX MD pencil scanner
with software version 1.3 g (Lunar Radiation Corp., Madison, WI,
USA), and also using the DPX machine (Lunar Radiation Corp.).
Scanning was carried out with the patient in the supine position.
The examined areas were the lumbar vertebrae and the left femoral
neck. The graph display showed the total BMD in g/cm2 in relation
to age, its age-matched percentage (Z-score), and its peak reference
percentage (T-score), taking into consideration the patients' sex,
weight, and height.
The World Health Organization deﬁned osteopenia as a BMD T-
score between 1 and 2.5, and deﬁned osteoporosis as a T-score
of 2.5 or less.15
2.3. Laboratory assessment
Vitamin B12 level was estimated using the fully automated
UniCel DxI 600 Immunoassay System (access from Beckman and
Coulter, Brea, California, USA). This device used a two-step
competitive binding technique. The analytical sensitivity of this
assay was 50 pg/mL. The analytical measurement range was
50e1500 pg/mL, and a total assay imprecision of 12% was found as
the measurement range. Vitamin B12 levels were evaluated as
follows16; normal range: >350 pg/mL, borderline range:
200e350 pg/mL, and deﬁcient range: < 200 pg/mL.The researchers notiﬁed and gave recommendations for treat-
ment to all vitamin B12-deﬁcient patients identiﬁed and to those
within the borderline vitamin B12 range.
2.4. Ethical considerations
Informed consent was obtained from all the participants in this
study. The study methodology was reviewed and approved by the
Research Review Board of the Geriatrics and Gerontology Depart-
ment, Faculty of Medicine, Ain Shams University.
2.5. Statistical methods
The collected data was coded, tabulated, revised, and statisti-
cally analyzed using SPSS version 16 (SPSS Inc., Chicago, IL, USA).
Quantitative variables were presented in the form of means and
standard deviations. Qualitative variables were presented in the
form of frequency tables (number and percent). Comparisons be-
tween quantitative variables were done using student t test or
analysis of variance (ANOVA), and between qualitative variables
using Pearson's Chi-square test.
3. Results
The characteristics of the two study groups are shown in Table 1.
There was no signiﬁcant difference between the study groups
regarding age, BMI, history of previous fractures, bone health sta-
tus, lumbar spine BMD, left femur BMD, and physical performance
assessed by activities of daily living17 and instrumental activities of
daily living.18
The group with DM had more fallers than the control group
(p ¼ 0.05). Borderline/deﬁcient serum B12 status was more com-
mon in the control group (16/30 patients; 53.33%) compared with
the patients with DM (8/31 patients; 25.80%); this difference was
statistically signiﬁcant (p ¼ 0.04). Although not reaching statistical
signiﬁcance, the mean serum vitamin B12 level was higher in the
diabetic group.
In the current study, 11 (35.5%) of the diabetic patients had
ischemic heart disease, eight (25.80%) patients were hypertensive,
ﬁve (16.1%) patients had heart failure, two (6.50%) patients had
chronic obstructive pulmonary disease, and ﬁve (16.13%) cases re-
ported no comorbidity.
Among the cases with DM, the osteoporotic patients were older
compared with patients with osteopenia and normal patients
(p ¼ 0.005). None of the diabetic patients with osteoporosis used
metformin, whereas two patients with osteopenia received met-
formin. There was no signiﬁcant relationship between the occur-
rence of osteoporosis and serum B12 level, insulin use, smoking,
sex, or BMI (Table 2).
Table 3 showed that there was no signiﬁcant difference between
diabetic females and males in regard to age, serum B12 concen-
trations, left femoral neck BMD, and lumbar spine BMD. Diabetic
females were more obese than males.
There was no linear relationship between serum vitamin B12
concentrations and BMD at the lumbar spine and left femoral neck
(Fig. 1).
4. Discussion
In this study, there was no signiﬁcant difference between the
two study groups in regard to the prevalence of osteoporosis or
osteopenia. Similarly, no signiﬁcant difference was found between
the two groups regarding the mean BMD at the lumbar spine or left
femoral neck; therefore, the occurrence of osteoporosis is not
Table 1
Comparison of variables studied between the study groups.
Diabetic patients not receiving vitamin B12 supplements
N ¼ 31
Controls not receiving vitamin B12 supplements
N ¼ 30
p
Age (y) 65.03 ± 4.9 66.8 ± 8.08 0.36
BMI (kg/m2) 33.20 ± 9.9 29.20 ± 6.56 0.07
Smoking Ex-smoker 6 (19.35) 0 0.03
Nonsmoker 20 (64.5) 22 (73.33)
Current 5 (16.12) 8 (26.67)
History of previous falls 6 (19.35) 1 (3.33) 0.05 *
History of previous fractures 0 (0) 1 (3.33) 0.30
Bone health status Normal 10 (32.26) 7 (23.33) 0.62
Osteopenia 10 (32.26) 13 (43.33)
Osteoporosis 11 (35.48) 10 (33.33)
ADL Assisted 5 (16.12) 2 (6.7) 0.29
Dependent 1 (3.22) 0
Independent 25 (80.64) 28 (93.33)
IADL Assisted 9 (29.03) 6 (20) 0.229
Dependent 2 (6.45) 0
Independent 20 (64.51) 24 (80)
Serum B12 status Borderline 6 (19.35) 13 (43.3) 0.04 *
Deﬁcient 2 (6.45) 3 (10)
Normal 23 (74.19) 14 (46.67)
Serum B12 (pg/mL) 820.65 ± 544.77 677.80 ± 619.89 0.34
Lumbar spine BMD (g/cm2) 0.96 ± 0.18 0.92 ± 0.13 0.31
Left femur BMD (g/cm2) 0.893 ± 0.17 0.87 ± 0.18 0.62
Data are presented as n (%) or mean ± standard deviation.
*Statistically signiﬁcant.
ADL ¼ activity of daily living; BMI ¼ body mass index; BMD ¼ bone mineral density; IADL ¼ instrumental activity of daily living.
Table 2
Comparison between different densitometry categories and different variables among the diabetic group.
Normal
N ¼ 10
Osteopenia
N ¼ 10
Osteoporotic
N ¼ 11
p
Age (y) 65.20 ± 4.9 62.20 ± 1.5 68.43 ± 4.45 0.005 *
Sex Male 6 (60) 3 (30.0) 7 (63.63) 0.24
Female 4 (40.0) 7 (70.0) 4 (36.36)
Body mass index (kg/m2) 38.83 ± 11.94 30.46 ± 2.09 30.56 ± 2.73 0.09
Smoking Ex-smoker 1 (10.0) 2 (20.0) 3 (27.27) 0.83
Nonsmoker 7 (70.0) 7 (70.0) 6 (54.54)
Current smoker 2 (20.0) 1 (10.0) 2 (18.18)
Serum vitamin B12 level (pg/mL) 823.20 ± 530.24 539.50 ± 400.79 1073.9 ± 585.78 0.07
ADL Assisted 2 (20.0) 0 (0) 3 (27.27) 0.26
Dependent 0 (0) 0 (0) 1 (9.09)
Independent 8 (80.0) 10 (100.0) 7 (63.63)
IADL Assisted 4 (40.0) 1 (10.0) 4 (36.36) 0.128
Dependent 0 (0) 0 (0) 2 (18.18)
Independent 6 (60) 9 (90.0) 5 (45.45)
Left femur BMD (g/cm2) 1.07 ± 0.15 0.87 ± 0.26 0.743 ± 0.09 0.000 *
Lumbar spine BMD (g/cm2) 1.33 ± 0.10 1.03 ± 0.09 0.93 ± 0.17 0.000 *
Metformin use 4 (40.0) 2 (20.0) 0 (0) 0.068
Other antidiabetic drugs use 1 (10.0) 2 (20.0) 2 (18.18) 0.076
Insulin use 6 (60) 8 (80.0) 9 (81.81) 0.344
Data are presented as n (%) or mean ± standard deviation.
*Statistically signiﬁcant.
ADL ¼ activity of daily living; BMD ¼ bone mineral density; IADL ¼ instrumental activity of daily living.
Table 3
The differences between both sexes among diabetics regarding the studied variables.
Females
N ¼ 15
Males
N ¼ 16
p
Age (y) 65.00 ± 4.70 65.42 ± 5.66 0.13
BMI 37.91 ± 8.30 29.31 ± 6.25 0.004 *
Serum B12 concentration (pg/mL) 918.77 ± 492.68 865.39 ± 523.78 0.63
Left femoral BMD (gm/cm2) 0.840 ± 0.128 0.892 ± 0.175 0.74
Spine BMD (gm/cm2) 0.993 ± 0.135 1.10 ± 0.222 0.19
Data are presented as the mean ± standard deviation.
*Statistically signiﬁcant.
BMD ¼ bone mineral density; BMI ¼ body mass index.
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when analyzing males and females, separately.
This agrees with Maghbooli et al19 who found no signiﬁcant
difference in the prevalence of osteopenia and osteoporosis be-
tween patients with type 2 DM and participants without diabetes.
Moreover, Al-Elq and Sadat-Ali20 studied 154 male Saudi Arabian
patients and reported that the presence of type 2 DM did not in-
ﬂuence the incidence of osteopenia or osteoporosis in males.
Regarding the female sex, Gupta et al21 reported that premen-
opausal Arabwomenwith type 2 DM had a higher BMD at the spine
than women without diabetes with a matched BMI. This was
explained by diffuse osteoarthritis at the vertebral site in diabetic
women, which can lead to false elevated values of BMD at this
Fig. 1. Relationship between serum vitamin B 12 concentrations and bone mineral density (BMD) at the lumbar spine and left femur neck in diabetics. Among diabetics, there was
no linear relationship between serum vitamin B 12 concentrations and BMD at the lumbar spine and left femur neck.
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DM patients have signiﬁcantly lower T-score values and a greater
frequency of osteoporosis than healthy postmenopausal women.
Contradictory results for vitamin B12 levels in diabetic patients
have been reported. Furthermore, there is little information, if any,
regarding vitamin B12 status in Egyptian elders. In the current
study, low serum vitamin B12 concentration was found in a
considerable number of the studied patients. Twenty four (39.35%)
patients were found to have either deﬁcient or borderline serum
vitamin B12 levels.
However, our results showed that borderline/deﬁcient serum
vitamin B12 status was more common in the control group (16/30
patients; 53.33%) compared with patients with DM (only 8/31 pa-
tients who did not receive oral vitamin B12 supplements; 25.80%),
and this difference was found to be statistically signiﬁcant
(p ¼ 0.04). The mean serum vitamin B12 concentration was
820.65 ± 544.7 pg/mL in patients with diabetes and
677.80 ± 619.89 pg/mL in healthy participants (p ¼ 0.34).
This was similar to a study by Delen et al,24 who reported that
serum vitamin B12 levels were higher in patients with type 2 DM
compared with the controls, however, this difference was not sta-
tistically signiﬁcant. El Oudi et al25 also found that diabetic cases
had elevated serum levels of vitamin B12 (p < 0.001) compared
with the controls. This higher serum level of vitamin B12 in patients
with DM was explained by cytosolic metabolic resistance to
vitamin B12 in those patients.26
Some researchers, however, reported a higher prevalence of
vitamin B12 deﬁciency in patients with DM.13 In their study, the
daily use of >2000 mg of metformin was associated with a higher
prevalence of vitamin B12 deﬁciency.
In the present study, only 19.40% of the patients with diabetes
received metformin, with a mean dose of 925.00 ± 442.43 mg/d; it
was found that there was no signiﬁcant difference between pa-
tients taking metformin and those who did not take metformin, in
regard to their mean serum B12 level or the prevalence of vitamin
B12 deﬁciency.
Another target of our study was to assess the effects of serum
vitamin B12 levels on bone mass. Serum vitamin B12 concentration
showed no signiﬁcant difference between osteoporotic, osteopenic,
and normal participants in both groups. Regarding the generalpopulation, many other studies did not observe the association
between vitamin B12 status and BMD.12,13 By contrast, many
studies reported a signiﬁcant association between low vitamin B12
and osteoporosis.11,27,28
Besides the current study, only two other studies have assessed
the relationship between vitamin B12 and BMD, speciﬁcally in
patients with diabetes.29,30 Both studies found that homocysteine
was inversely correlated with BMD; however, there was no signif-
icant association between BMD and the serum concentrations of
vitamin B12. Furthermore, they concluded that metformin did not
have a signiﬁcant effect on serum vitamin B12 status.29,30
The exact mechanisms by which vitamin B12 can affect bone
health remains unclear, however, data indicates that vitamin B12
deﬁciency, when causing hyperhomocysteinemia, may increase
osteoclast formation and bone resorption, while higher B12 levels
may affect osteoblast maturation.31 The contradictory results
regarding the relationship of vitamin B12 level and BMD, obtained
from different studies, may be explained by differences in the mean
age and sex distribution of the study populations, genetic differ-
ences between different study populations, and the level of
adjustment for other confounders affecting bone health.
Our study had several limitations; ﬁrstly, due to the small
sample size, its statistical power might be insufﬁcient. Secondly, we
did not examine multiple confounders that may contribute to
mineral-bone metabolism, e.g., the serum levels of calcium,
1,25(OH)2D, dietary phosphorus, and calcium intake. Thirdly, we
did not examine plasma homocysteine levels which may play a role
in the occurrence of osteoporosis independent of vitamin B12
levels.
5. Conclusion
Surprisingly, we found that BMD was not related to serum
vitamin B12 concentration in diabetics as well as in controls. Serum
vitamin B12 concentration may be normal or even high in elderly
patients with type 2 DM, making the decision of vitamin B12
supplementation a complex one. Vitamin B12 deﬁciency was more
common in elderly nondiabetics than in diabetics. The exact
mechanism of higher vitamin B12 levels among diabetics should be
studied.
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